{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:57:30Z","timestamp":1793055450717,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R325-A18625"],"award-info":[{"award-number":["R325-A18625"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inge & J\u00f8rgen Larsens Mindelegat","award":["10537-006\/41"],"award-info":[{"award-number":["10537-006\/41"]}]},{"DOI":"10.13039\/100018732","name":"Vissing Fonden","doi-asserted-by":"publisher","award":["525902"],"award-info":[{"award-number":["525902"]}],"id":[{"id":"10.13039\/100018732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several techniques exist for performing targeted axillary dissection (TAD) after neoadjuvant chemotherapy with the removal of the sentinel node and a marked metastatic lymph node (LN). Two-step methods include coil-marking of the metastatic LN at diagnosis and re-marking with an intraoperatively identifiable marker before surgery. Because nondetection of the marked lymph node (MLN) warrants axillary clearance and many patients achieve axillary pathological complete response (ax-pCR), the success of TAD is crucial. We compare various two-step TAD methods in a Danish national cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included patients who received two-step TAD between January 1, 2016 and August 31, 2021. Patients were identified from the Danish Breast Cancer Group database and cross-checked with locally accessible lists. Data were extracted from the patient\u2019s medical files.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included 543 patients. In 79.4%, preoperative, ultrasound-guided re-marking was possible. Nonidentification of the coil-marked LN was more likely in patients with ax-pCR. The second markers used were hook-wire, iodine seeds, or ink marking on the axillary skin. Of patients with successful secondary marking, the MLN identification rate (IR) was 91%, and the sentinel node (SN) IR was 95%. Marking with iodine seeds was significantly more successful than ink marking with an odds ratio of 5.34 (95% confidence interval 1.62-17.60). The success rate of the complete TAD with the removal of MLN and SN was 82.3%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>With two-step TAD, nonidentification of the coiled LN before surgery is frequent, especially in patients with ax-pCR. Despite successful remarking, the IR of the MLN at surgery is inferior to one-step TAD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-023-13792-x","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T17:01:35Z","timestamp":1688403695000},"page":"6361-6369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7659-7825","authenticated-orcid":false,"given":"Frederikke","family":"Munck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Zeuthen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Carstensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Hauerslev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian K.","family":"Paaskesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge S.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"H\u00f8yer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lanng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Vejborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels T.","family":"Kroman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove H. F.","family":"Tvedskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"issue":"3","key":"13792_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejso.2015.11.018","volume":"42","author":"IT Rubio","year":"2016","unstructured":"Rubio IT. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress. Eur J Surg Oncol. 2016;42(3):326\u201332. https:\/\/doi.org\/10.1016\/j.ejso.2015.11.018.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"13792_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/bjs\/znac217","volume":"109","author":"ML Gasparri","year":"2022","unstructured":"Gasparri ML, de Boniface J, Poortmans P, et al. Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey. Br J Surg. 2022;109(9):857\u201363. https:\/\/doi.org\/10.1093\/bjs\/znac217.","journal-title":"Br J Surg."},{"issue":"14","key":"13792_CR3","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial. JAMA - J Am Med Assoc. 2013;310(14):1455\u201361. https:\/\/doi.org\/10.1001\/jama.2013.278932.","journal-title":"JAMA - J Am Med Assoc."},{"issue":"3","key":"13792_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201363. https:\/\/doi.org\/10.1200\/JCO.2014.55.7827.","journal-title":"J Clin Oncol."},{"issue":"5","key":"13792_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.amjsurg.2016.07.018","volume":"212","author":"Chehade H El Hage","year":"2016","unstructured":"El Hage Chehade H, Headon H, El Tokhy O, Heeney J, Kasem A, Mokbel K. Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients. Am J Surg. 2016;212(5):969\u201381. https:\/\/doi.org\/10.1016\/j.amjsurg.2016.07.018.","journal-title":"Am J Surg."},{"issue":"7","key":"13792_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318. https:\/\/doi.org\/10.1016\/S1470-2045(13)70166-9.","journal-title":"Lancet Oncol."},{"issue":"1","key":"13792_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-017-4164-1","volume":"163","author":"LH Zetterlund","year":"2017","unstructured":"Zetterlund LH, Frisell J, Zouzos A, De Boniface J. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer. Breast Cancer Res Treat. 2017;163(1):103\u201310. https:\/\/doi.org\/10.1007\/s10549-017-4164-1.","journal-title":"Breast Cancer Res Treat."},{"issue":"7","key":"13792_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/cancers13071565","volume":"13","author":"M Banys-paluchowski","year":"2021","unstructured":"Banys-paluchowski M, Gasparri ML, de Boniface J, et al. Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the eubreast-03 axsana study. Cancers (Basel). 2021;13(7):1565. https:\/\/doi.org\/10.3390\/cancers13071565.","journal-title":"Cancers (Basel)."},{"issue":"12","key":"13792_CR9","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","volume":"23","author":"EP Mamounas","year":"2005","unstructured":"Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol. 2005;23(12):2694\u2013702. https:\/\/doi.org\/10.1200\/JCO.2005.05.188.","journal-title":"J Clin Oncol."},{"key":"13792_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1507881","volume":"22","author":"S Aragon-Sanchez","year":"2022","unstructured":"Aragon-Sanchez S, Oliver-Perez MR, Madariaga A, et al. Accuracy and limitations of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive nodes. Breast J. 2022;22:1\u20138. https:\/\/doi.org\/10.1155\/2022\/1507881.","journal-title":"Breast J."},{"issue":"10","key":"13792_CR11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072\u20138. https:\/\/doi.org\/10.1200\/JCO.2015.64.0094.","journal-title":"J Clin Oncol."},{"issue":"5","key":"13792_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","volume":"23","author":"EJ Diego","year":"2016","unstructured":"Diego EJ, McAuliffe PF, Soran A, et al. Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes. Ann Surg Oncol. 2016;23(5):1549\u201353. https:\/\/doi.org\/10.1245\/s10434-015-5052-8.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"13792_CR13","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","volume":"25","author":"C Siso","year":"2018","unstructured":"Siso C, de Torres J, Esgueva-Colmenarejo A, et al. Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA Trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment. Ann Surg Oncol. 2018;25(3):784\u201391. https:\/\/doi.org\/10.1245\/s10434-017-6270-z.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"13792_CR14","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/bjs.7073","volume":"97","author":"ME Straver","year":"2010","unstructured":"Straver ME, Loo CE, Alderliesten T, Rutgers EJT, Vrancken Peeters MTFD. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010;97(8):1226\u201331. https:\/\/doi.org\/10.1002\/bjs.7073.","journal-title":"Br J Surg."},{"issue":"2","key":"13792_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","volume":"150","author":"AS Caudle","year":"2015","unstructured":"Caudle AS, Yang WT, Mittendorf EA, et al. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg. 2015;150(2):137\u201343. https:\/\/doi.org\/10.1001\/jamasurg.2014.1086.","journal-title":"JAMA Surg."},{"issue":"2","key":"13792_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","volume":"261","author":"M Donker","year":"2015","unstructured":"Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378\u201382. https:\/\/doi.org\/10.1097\/SLA.0000000000000558.","journal-title":"Ann Surg."},{"key":"13792_CR17","doi-asserted-by":"publisher","first-page":"101636","DOI":"10.1016\/j.suronc.2021.101636","volume":"38","author":"D Flores-Funes","year":"2021","unstructured":"Flores-Funes D, Aguilar-Jim\u00e9nez J, Mart\u00ednez-G\u00e1lvez M, et al. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: definitive results. Surg Oncol. 2021;38:101636. https:\/\/doi.org\/10.1016\/j.suronc.2021.101636.","journal-title":"Surg Oncol."},{"issue":"3","key":"13792_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/ans.15604","volume":"90","author":"K Kanesalingam","year":"2020","unstructured":"Kanesalingam K, Sriram N, Heilat G, et al. Targeted axillary dissection after neoadjuvant systemic therapy in patients with node-positive breast cancer. ANZ J Surg. 2020;90(3):332\u20138. https:\/\/doi.org\/10.1111\/ans.15604.","journal-title":"ANZ J Surg."},{"issue":"2","key":"13792_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1245\/s10434-014-4034-6","volume":"22","author":"N Choy","year":"2015","unstructured":"Choy N, Lipson J, Porter C, et al. Initial results with pre-operative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients. Ann Surg Oncol. 2015;22(2):377\u201382. https:\/\/doi.org\/10.1245\/s10434-014-4034-6.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"13792_CR20","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ejso.2019.12.007","volume":"46","author":"R Balasubramanian","year":"2020","unstructured":"Balasubramanian R, Morgan C, Shaari E, et al. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Eur J Surg Oncol. 2020;46(6):1028\u201333. https:\/\/doi.org\/10.1016\/j.ejso.2019.12.007.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"13792_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.7759\/cureus.14610","volume":"13","author":"M Beniey","year":"2021","unstructured":"Beniey M, Boulva K, Rodriguez-Qizilbash S, Kaviani A, Younan R, Patocskai E. Targeted axillary dissection in node-positive breast cancer: a retrospective study and cost analysis. Cureus. 2021;13(4):146. https:\/\/doi.org\/10.7759\/cureus.14610.","journal-title":"Cureus."},{"key":"13792_CR22","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform."},{"issue":"2","key":"13792_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform."},{"key":"13792_CR24","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Published online 2021. https:\/\/www.r-project.org\/."},{"issue":"36","key":"13792_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.suronc.2020.11.013","volume":"2021","author":"A Mariscal Mart\u00ednez","year":"2020","unstructured":"Mariscal Mart\u00ednez A, Vives Rosell\u00f3 I, Salazar G\u00f3mez A, et al. Advantages of pre-operative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer. Surg Oncol. 2020;2021(36):28\u201333. https:\/\/doi.org\/10.1016\/j.suronc.2020.11.013.","journal-title":"Surg Oncol."},{"issue":"9","key":"13792_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","volume":"44","author":"S Hartmann","year":"2018","unstructured":"Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol. 2018;44(9):1307\u201311. https:\/\/doi.org\/10.1016\/j.ejso.2018.05.035.","journal-title":"Eur J Surg Oncol."},{"issue":"10","key":"13792_CR27","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1245\/s10434-017-6023-z","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hieken TJ, Glazebrook KN, Boughey JC. Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges. Ann Surg Oncol. 2017;24(10):3011\u20136. https:\/\/doi.org\/10.1245\/s10434-017-6023-z.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"13792_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10549-021-06416-z","volume":"191","author":"JL Baker","year":"2022","unstructured":"Baker JL, Haji F, Kusske AM, et al. SAVI SCOUT\u00ae localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study. Breast Cancer Res Treat. 2022;191(1):107\u201314. https:\/\/doi.org\/10.1007\/s10549-021-06416-z.","journal-title":"Breast Cancer Res Treat."},{"issue":"May","key":"13792_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.suronc.2019.05.019","volume":"30","author":"D Flores-Funes","year":"2019","unstructured":"Flores-Funes D, Aguilar-Jim\u00e9nez J, Mart\u00ednez-G\u00e1lvez M, et al. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results. Surg Oncol. 2019;30(May):52\u20137. https:\/\/doi.org\/10.1016\/j.suronc.2019.05.019.","journal-title":"Surg Oncol."},{"issue":"6","key":"13792_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4174\/astr.2021.100.6.305","volume":"100","author":"G Gurleyik","year":"2021","unstructured":"Gurleyik G, Aksu SA, Aker F, Tekyol KK, Tanrikulu E, Gurleyik E. Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy. Ann Surg Treat Res. 2021;100(6):305\u201312. https:\/\/doi.org\/10.4174\/astr.2021.100.6.305.","journal-title":"Ann Surg Treat Res."},{"issue":"6","key":"13792_CR31","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cam4.2848","volume":"9","author":"GH Lim","year":"2020","unstructured":"Lim GH, Teo SY, Gudi M, et al. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: skin mark clipped axillary nodes removal technique (SMART trial). Cancer Med. 2020;9(6):1978\u201385. https:\/\/doi.org\/10.1002\/cam4.2848.","journal-title":"Cancer Med."},{"issue":"4","key":"13792_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12282-022-01349-x","volume":"29","author":"CS Pinto","year":"2022","unstructured":"Pinto CS, Peleteiro B, Pinto CA, et al. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients. Breast Cancer. 2022;29(4):709\u201319. https:\/\/doi.org\/10.1007\/s12282-022-01349-x.","journal-title":"Breast Cancer."},{"key":"13792_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","volume":"157","author":"JM Simons","year":"2022","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, Kam BLR, Lobbes MBI, de Boer M, Verhoef C, Sars PRA, Heijmans HJ, van Haaren ERM, Vles WJ, Contant CME, Menke-Pluijmers MBE, Smit LHM, Kelder W, Boskamp M, Koppert LB, Smidth M. Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. JAMA Surg. 2022;157:991. https:\/\/doi.org\/10.1001\/jamasurg.2022.3907.","journal-title":"JAMA Surg."},{"key":"13792_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/S10549-022-06588-2","author":"J de Boniface","year":"2022","unstructured":"de Boniface J, Frisell J, K\u00fchn T, et al. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy. Breast Cancer Res Treat. 2022. https:\/\/doi.org\/10.1007\/S10549-022-06588-2.","journal-title":"Breast Cancer Res Treat."},{"key":"13792_CR35","first-page":"57","volume":"21","author":"F Munck","year":"2011","unstructured":"Munck F, Andersen I, Vejborg I, Lanng C, Tvedskov T. Targeted axillary dissection with 125i seed placement before neoadjuvant chemotherapy in a Danish multicenter cohort. Ann Surg Oncol. 2011;21:57.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"13792_CR36","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","volume":"269","author":"JM Simons","year":"2019","unstructured":"Simons JM, Van Nijnatten TJA, Van Der Pol CC, Luiten EJT, Koppert LB, Smidt ML. Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2019;269(3):432\u201342. https:\/\/doi.org\/10.1097\/SLA.0000000000003075.","journal-title":"Ann Surg."},{"issue":"4","key":"13792_CR37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/sla.0000000000000924","volume":"260","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, McCall LM, Ballman KV, et al. Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer. Ann Surg. 2014;260(4):608\u201316. https:\/\/doi.org\/10.1097\/sla.0000000000000924.","journal-title":"Ann Surg."},{"issue":"6","key":"13792_CR38","doi-asserted-by":"publisher","first-page":"210891","DOI":"10.1001\/jamasurg.2021.0891","volume":"156","author":"S Samiei","year":"2021","unstructured":"Samiei S, Simons JM, Sanne ME, et al. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease a systematic review and meta-analysis supplemental content. JAMA Surg. 2021;156(6):210891. https:\/\/doi.org\/10.1001\/jamasurg.2021.0891.","journal-title":"JAMA Surg."},{"issue":"10","key":"13792_CR39","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1245\/s10434-018-6575-6","volume":"25","author":"N Cab\u0131o\u011flu","year":"2018","unstructured":"Cab\u0131o\u011flu N, Karanl\u0131k H, Kangal D, et al. Improved false-negative rates with intraoperative identification of clipped nodes in patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25(10):3030\u20136. https:\/\/doi.org\/10.1245\/s10434-018-6575-6.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"13792_CR40","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KK. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0\u2013T4, N1\u2013N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Annals of Surgery. 2016;263(4):802\u20137. https:\/\/doi.org\/10.1097\/SLA.0000000000001375.","journal-title":"Annals of Surgery"},{"issue":"1","key":"13792_CR41","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.clbc.2021.07.011","volume":"22","author":"SR de Wild","year":"2022","unstructured":"de Wild SR, Simons JM, Vrancken Peeters MJTFD, Smidt ML, Koppert LB. MINImal vs. MAXimal invasive axillary staging and treatment after neoadjuvant systemic therapy in node positive breast cancer: protocol of a dutch multicenter registry study (MINIMAX). Clin Breast Cancer. 2022;22(1):e59\u201364. https:\/\/doi.org\/10.1016\/j.clbc.2021.07.011.","journal-title":"Clin Breast Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13792-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T14:04:59Z","timestamp":1695045899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13792-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["13792"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13792-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}